These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 9973458)

  • 1. Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway.
    Guermonprez P; Ladant D; Karimova G; Ullmann A; Leclerc C
    J Immunol; 1999 Feb; 162(4):1910-6. PubMed ID: 9973458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming.
    Schlecht G; Loucka J; Najar H; Sebo P; Leclerc C
    J Immunol; 2004 Nov; 173(10):6089-97. PubMed ID: 15528345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charge-dependent translocation of Bordetella pertussis adenylate cyclase toxin into eukaryotic cells: implication for the in vivo delivery of CD8(+) T cell epitopes into antigen-presenting cells.
    Karimova G; Fayolle C; Gmira S; Ullmann A; Leclerc C; Ladant D
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12532-7. PubMed ID: 9770520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway.
    Song R; Harding CV
    J Immunol; 1996 Jun; 156(11):4182-90. PubMed ID: 8666786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class I-restricted presentation of maleylated protein binding to scavenger receptors.
    Bansal P; Mukherjee P; Basu SK; George A; Bal V; Rath S
    J Immunol; 1999 Apr; 162(8):4430-7. PubMed ID: 10201979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo, dendritic cells can cross-present virus-like particles using an endosome-to-cytosol pathway.
    Morón VG; Rueda P; Sedlik C; Leclerc C
    J Immunol; 2003 Sep; 171(5):2242-50. PubMed ID: 12928368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tapasin-/- and TAP1-/- macrophages are deficient in vacuolar alternate class I MHC (MHC-I) processing due to decreased MHC-I stability at phagolysosomal pH.
    Chefalo PJ; Grandea AG; Van Kaer L; Harding CV
    J Immunol; 2003 Jun; 170(12):5825-33. PubMed ID: 12794107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo.
    Fayolle C; Bauche C; Ladant D; Leclerc C
    Vaccine; 2004 Dec; 23(5):604-14. PubMed ID: 15542180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites.
    Osicka R; Osicková A; Basar T; Guermonprez P; Rojas M; Leclerc C; Sebo P
    Infect Immun; 2000 Jan; 68(1):247-56. PubMed ID: 10603395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages.
    Tobian AA; Canaday DH; Boom WH; Harding CV
    J Immunol; 2004 May; 172(9):5277-86. PubMed ID: 15100266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway.
    Carbonetti NH; Irish TJ; Chen CH; O'Connell CB; Hadley GA; McNamara U; Tuskan RG; Lewis GK
    Infect Immun; 1999 Feb; 67(2):602-7. PubMed ID: 9916065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation.
    Wick MJ; Pfeifer JD
    Eur J Immunol; 1996 Nov; 26(11):2790-9. PubMed ID: 8921970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
    Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope.
    Fayolle C; Ladant D; Karimova G; Ullmann A; Leclerc C
    J Immunol; 1999 Apr; 162(7):4157-62. PubMed ID: 10201941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells.
    Serna A; Ramirez MC; Soukhanova A; Sigal LJ
    J Immunol; 2003 Dec; 171(11):5668-72. PubMed ID: 14634072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial proteins can be processed by macrophages in a transporter associated with antigen processing-independent, cysteine protease-dependent manner for presentation by MHC class I molecules.
    Campbell DJ; Serwold T; Shastri N
    J Immunol; 2000 Jan; 164(1):168-75. PubMed ID: 10605008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis.
    Mukherjee P; Dani A; Bhatia S; Singh N; Rudensky AY; George A; Bal V; Mayor S; Rath S
    J Immunol; 2001 Sep; 167(5):2632-41. PubMed ID: 11509605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant and protective properties of native and recombinant Bordetella pertussis adenylate cyclase toxin preparations in mice.
    Hormozi K; Parton R; Coote J
    FEMS Immunol Med Microbiol; 1999 Apr; 23(4):273-82. PubMed ID: 10225286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-receptive class I major histocompatibility complex molecules on TAP-deficient and wild-type cells and their roles in the processing of exogenous antigens.
    Song R; Porgador A; Harding CV
    Immunology; 1999 Jun; 97(2):316-24. PubMed ID: 10447748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.